The arrival of Retatrutide in the UK is generating significant anticipation within the weight management community. This groundbreaking dual compound – targeting both GLP-1 and GIP – suggests a remarkably new solution to combating obesity . Until recently, options have been restricted for many, and Retatrutide embodies a encouraging prospect fo